|
?:authorAffiliation
|
-
[\'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. yunda@scharp.org.\', \'Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. yunda@scharp.org.\', \'Department of Global Health, University of Washington, Seattle, WA, USA. yunda@scharp.org.\', \'Biomedical Advanced Research and Development Authority, Washington, DC, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'LabCorp-Monogram Biosciences, South San Francisco, CA, USA.\', \'Department of Surgery, Duke University Medical Center, Durham, NC, USA.\', \'Department of Immunology, Duke University Medical Center, Durham, NC, USA.\', \'Moderna, Inc., Cambridge, MA, USA.\', \'Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.\', \'Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.\', \'Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, USA.\', \'Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Biostatistics, University of Washington, Seattle, WA, USA.\', \'Department of Surgery, Duke University Medical Center, Durham, NC, USA. david.montefiori@duke.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}